bupivacaine has been researched along with chitosan in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Bernardo, MV; Blanco, MD; Sastre, RL; Teijón, C; Teijón, JM | 1 |
de Araújo, DR; de Melo, NF; de Paula, E; Fraceto, LF; Grillo, R; Rosa, AH | 1 |
Barenholz, Y; Cohen, R; Grant, GJ; Kanaan, H | 1 |
Allegri, M; Balliano, MA; Corradetti, B; Minardi, S; Taraballi, F; Tasciotti, E; Van Eps, JL; Yazdi, IK | 1 |
Al Homsi, R; Ali Abdelkareem, M; Eltahir, S; Ghoneim, MM; Greish, K; Haider, M; Jagal, J; Rawas-Qalaji, MM | 1 |
Asadi, AA; Atyabi, F; Habibi, S; HMTShirazi, R; Kiani, M; Mohammadi, T | 1 |
Chitumalla, RK; Choi, S; Chung, I; Ha, CS; Jang, J; Jung, Y; Nagella, SR; Park, SY; Yoon, JY | 1 |
7 other study(ies) available for bupivacaine and chitosan
Article | Year |
---|---|
Sustained release of bupivacaine from devices based on chitosan.
Topics: Bupivacaine; Chitin; Chitosan; Delayed-Action Preparations | 2003 |
Polymeric alginate nanoparticles containing the local anesthetic bupivacaine.
Topics: Alginates; Anesthetics, Local; Animals; Bupivacaine; Chitosan; Drug Stability; Glucuronic Acid; Hexuronic Acids; In Vitro Techniques; Male; Mice; Nanoparticles; Particle Size; Succinates | 2010 |
Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability.
Topics: Alginates; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Chitosan; Cross-Linking Reagents; Drug Carriers; Drug Design; Drug Stability; Drug Storage; Electric Stimulation; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Subcutaneous; Liposomes; Male; Mice; Time Factors | 2012 |
Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.
Topics: Anesthetics, Local; Animals; Bupivacaine; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; Inflammation Mediators; Kinetics; Lactic Acid; Macrophages; Mice; Particle Size; Phagocytosis; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Technology, Pharmaceutical | 2014 |
Thermosensitive injectable graphene oxide/chitosan-based nanocomposite hydrogels for controlling the in vivo release of bupivacaine hydrochloride.
Topics: Animals; Bupivacaine; Chitosan; Graphite; Hydrogels; Nanogels; Rats | 2022 |
A bilayer mupirocin/bupivacaine-loaded wound dressing based on chitosan/poly (vinyl alcohol) nanofibrous mat: Preparation, characterization, and controlled drug release.
Topics: Anti-Bacterial Agents; Bandages; Bupivacaine; Chitosan; Drug Liberation; Mupirocin; Nanofibers; Polyvinyl Alcohol; Staphylococcus aureus | 2023 |
Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine.
Topics: Bupivacaine; Chitosan; Drug Carriers; Hydrogen-Ion Concentration; Nanogels; Nanoparticles | 2023 |